Z

Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332

Watchlist Manager
Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332
Watchlist
Price: 10.24 CNY -0.68% Market Closed
Market Cap: 10.1B CNY

EV/EBITDA
Enterprise Value to EBITDA

12.5
Current
13.7
Median
12.7
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
12.5
=
Enterprise Value
8.9B CNY
/
EBITDA
714.2m CNY

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
8.9
2-Years Forward
EV/EBITDA
7.5
3-Years Forward
EV/EBITDA
6.5